Any feedback?
Literature summary for 2.4.2.4 extracted from
- Heterogeneous ribonucleoprotein K and thymidine phosphorylase are independent prognostic and therapeutic markers for nasopharyngeal carcinoma (2008), Clin. Cancer Res., 14, 3807-3813.
Activating Compound
| Activating Compound | Comment | Organism | Structure |
|---|---|---|---|
| additional information | heterogeneous ribonucleoprotein K regulates thymidine phosphorylase mRNA stability | Homo sapiens |
Application
| Application | Comment | Organism |
|---|---|---|
| medicine | thymidine phosphorylase is an independent prognostic and therapeutic marker for nasopharyngeal carcinoma | Homo sapiens |
Organism
| Organism | UniProt | Comment | Textmining |
|---|---|---|---|
| Homo sapiens | - |
- |
- |
Source Tissue
| Source Tissue | Comment | Organism | Textmining |
|---|---|---|---|
| NPC-TW02 cell | - |
Homo sapiens | - |
Substrates and Products (Substrate)
| Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
|---|---|---|---|---|---|---|
| 5'-deoxy-5-fluorouridine + phosphate | - |
Homo sapiens | 5-fluorouracil + 5-deoxy-D-ribose 1-phosphate | - |
? |  |
| thymidine + phosphate | - |
Homo sapiens | thymine + 2-deoxy-D-ribose 1-phosphate | - |
? | |
Use of this online version of BRENDA is free under the CC BY 4.0 license. See terms of use for full details.
Release 2023.1 (January 2023)
Legal
Curated at
Member of
